3D Systems Corporation
NYSE•DDD
CEO: Dr. Jeffrey Alan Graves Ph.D.
Sector: Technology
Industry: Computer Hardware
Listing Date: 1988-03-10
3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, North Africa, the Asia Pacific, and Oceania. The company offers 3D printers technologies, such as stereolithography (SLA), selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes FOR automated support building and placement, build platform management, print simulation, and print queue management. Additionally, the company provides maintenance and training services; and precision healthcare solutions, such as design, planning, modeling, prototyping, manufacturing, printing, and finishing of medical and dental devices, anatomical models, and surgical guides and tools. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. The company was founded in 1986 and is headquartered in Rock Hill, South Carolina.
Contact Information
Market Cap
$311.55M
P/E (TTM)
4.7
37.9
Dividend Yield
--
52W High
$3.80
52W Low
$1.32
52W Range
Rank63Top 94.0%
1.8
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 1.8 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$106.28M+0.00%
4-Quarter Trend
EPS
-$0.15+0.00%
4-Quarter Trend
FCF
-$16.65M+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Net Income Turnaround Achieved $29.9M net income in 2025, reversing prior year's $255.6M loss, reflecting operational focus and cost control.
Cost Reduction Success SG&A expenses decreased $48.8M (23.2%) due to 2025 Restructuring Plan actions and lower compensation costs realized.
Strategic Asset Sales Completed divestitures of Geomagic and 3DXpert/Oqton, realizing $139.6M total pre-tax gain recognized during 2025.
Debt Restructuring Complete Issued $92.0M 2030 Notes, using proceeds to repurchase $179.7M of outstanding 2026 convertible notes in June 2025.
Risk Factors
ICFR Material Weaknesses Auditor issued adverse opinion due to material weaknesses in revenue SSP determination and stock compensation accounting controls.
Revenue Contraction Total revenue declined $53.2M (12.1%), primarily driven by lower materials volume in product sales segments during 2025.
Operating Cash Flow Strain Net cash used in operating activities increased to $87.8M in 2025, negatively impacting overall liquidity position.
Customer Concentration Risk Two Healthcare customers accounted for 23.6% of 2025 revenue, creating concentrated credit risk exposure for receivables.
Outlook
ICFR Remediation Focus Finalizing automation tool implementation for SSP determination, scheduled for completion within fiscal year 2026 to address control deficiencies.
Additive Manufacturing Scale Strategy centers on scaling additive manufacturing adoption across Healthcare and Industrial vertical solutions via Applications Innovation Group.
Restructuring Completion Expect no significant additional restructuring charges in 2026 related to the recently authorized 2025 Restructuring Plan.
Core R&D Investment Continue consistent investment in core R&D activities to support long-term growth opportunities post-transformation and cost savings.
Peer Comparison
Revenue (TTM)
$7.02B
$2.69B
$743.30M
Gross Margin (Latest Quarter)
75.1%
67.8%
64.2%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| RXT | $472.84M | -2.1 | 19.6% | 117.3% |
| MLAB | $430.71M | 115.5 | 2.1% | 23.8% |
| LSAK | $413.71M | -7.3 | -19.5% | 36.7% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
4.0%
Moderate Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
0%
Cash Flow Needs Attention
Deep Research
Next earnings:Mar 25, 2026
EPS:-$0.10
|Revenue:$97.99M
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data